Loading...
•
Mar 31, 2024
Select Medical Q1 2024 Earnings Report
Select Medical's Q1 2024 performance was marked by revenue growth and increased profitability.
Key Takeaways
Select Medical Holdings Corporation reported a 7.4% increase in revenue to $1,788.8 million for the first quarter ended March 31, 2024, compared to $1,665.0 million for the same quarter, prior year. Net income increased 37.4% to $117.2 million, and earnings per share increased 33.9% to $0.75.
Revenue increased by 7.4% to $1,788.8 million compared to the same quarter last year.
Net income increased by 37.4% to $117.2 million compared to the same quarter last year.
Earnings per share increased by 33.9% to $0.75 compared to the same quarter last year.
Adjusted EBITDA increased by 22.4% to $261.9 million compared to the same quarter last year.
Select Medical
Select Medical
Select Medical Revenue by Segment
Revenue by Segment
Critical Illness Recovery Hospital Revenue
CapyFin.comRehabilitation Hospital Revenue
CapyFin.comOutpatient Rehabilitation Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
Select Medical is reaffirming its 2024 business outlook for revenue and adjusting its 2024 business outlook for Adjusted EBITDA and fully diluted earnings per share. Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $845 million to $885 million, fully diluted earnings per share to be in the range of $1.95 to $2.19 and adjusted earnings per share to be in the range of $1.96 to $2.20.
Positive Outlook
- Revenue expected to be in the range of $6.9 billion to $7.1 billion.
- Adjusted EBITDA expected to be in the range of $845 million to $885 million.
- Fully diluted earnings per share expected to be in the range of $1.95 to $2.19.
- Adjusted earnings per share expected to be in the range of $1.96 to $2.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income